A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease (NCT07571746)

🧪 Interventions in This Study

• Surovatamig (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (24 Sites)

• Research Site — Los Angeles, California
• Research Site — Los Angeles, California
• Research Site — Iowa City, Iowa
• Research Site — Bethesda, Maryland
• Research Site — New York, New York
• Research Site — Houston, Texas
• Research Site — Houston, Texas
• Research Site — Ieper,
• Research Site — Bordeaux,
• Research Site — Créteil,
• Research Site — Lyon,
• Research Site — Nantes,
• Research Site — Nîmes,
• Research Site — Düsseldorf,
• Research Site — München,
• Research Site — Brescia,
• Research Site — Rozzano,
• Research Site — Torino,
• Research Site — Verona,
• Research Site — Lodz,
• Research Site — Barcelona,
• Research Site — Madrid,
• Research Site — London,
• Research Site — Manchester,

📞 Contact the Study Coordinator

Phone: (877) 240-9479

Email: information.center@astrazeneca.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Primary Membranous Nephropathy

• A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy — Granada Hills, California
• A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy — San Francisco, California
• Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) — Montgomery, Alabama
• Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) — Loma Linda, California
• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) — Huntsville, Alabama
• A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy — Denver, Colorado

Explore by condition: All Primary Membranous Nephropathy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.